Genetics of Lesch's typology of alcoholism

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 2, 2008, Pages 423-427

  Samochowiec, Jerzy ^a   Kucharska Mazur, Jolanta ^a   Grzywacz, Anna ^a   Pelka Wysiecka, Justyna ^a   Mak, Monika ^a   Samochowiec, Agnieszka ^a,b   Bienkowski, Przemyslaw ^c  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF SZCZECIN   (Poland)

^c INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Alcoholism; Dopamine; Genetics; Lesch's typology; Serotonin

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; METHIONINE; SEROTONIN; VALINE;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA POLYMORPHISM; ETHNIC DIFFERENCE; EXON; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SEX DIFFERENCE; STRUCTURED INTERVIEW; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; CATECHOL O-METHYLTRANSFERASE; CONTROL GROUPS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, DOPAMINE D2; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 38749091760     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.09.013     Document Type: Article

References (50)

1. Arinami T., Gao M., Hamaguchi H., and Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 6 (1997) 577-582
2. Babor T., De Hofmann M., Boca F., Hesselbrock V., Meyer R., Dolinsky Z., et al. Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 49 (1992) 599-608
3. Bleich S., Degner D., Javaheripour K., Kurth C., and Kornhuber J. Homocysteine and alcoholism. J Neural Transm 60 (2000) 187-196
4. Bleich S., Bayerlein K., Reulbach U., Hillemacher T., Bonsch D., Mugele B., et al. Homocysteine levels in patients classified according to Lesch's typology. Alcohol Alcohol 39 (2004) 493-498
5. Bonsch D., Bayerlein K., Reulbach U., Fiszer R., Hillemacher T., Sperling W., et al. Different allele-distribution of mthfr 677 C->T and mthfr -393 C-> a in patients classified according to subtypes of Lesch's typology. Alcohol Alcohol 41 (2006) 364-367
6. Buckland P.R. Genetic association studies of alcoholism problems with the candidate gene approach. Alcohol Alcohol 39 (2001) 99-103
7. Chick J., Howlett H., Morgan M.Y., and Ritson B. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol 35 (2000) 176-187
8. Cloninger C.R., Bohman M., and Sigvardsson S. Inheritance alcohol abuse: cross fostering analysis of adopted men. Arch Gen Psychiatry 38 (1981) 861-868
9. Connor J., Young R., Lawford B., Ritchie T., and Noble E. D(2) dopamine receptor (DRD2) polymorphism is associated with severity of alcohol dependence. Eur Psychiatry 17 (2002) 17-23
10. Finckh U., Rommelspacher H., Kuhn S., Dufeu P., Otto G., Heinz A., et al. Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics 7 (1997) 271-281
11. Heils A., Teufel A., Petri S., Stober G., Riederer P., and Bengel D. Allelic variation of human serotonin transporter gene expression. J Neurochem 66 (1996) 2621-2624
12. Heinz A., Goldman D., Gallinat J., Schumann G., and Puls I. Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence. Psychopharmacology 174 (2004) 561-570
13. Hesselbrock M., Easton C., Bucholz K., Schuckit M., and Hesselbrock V. A validity study of the SSAGA - a comparison with the SCAN. Addiction 94 (1999) 1361-1370
14. Hillemacher T., Bayerlein K., Wilhelm J., Frieling H., Sperling W., Kornhuber J., et al. Prolactin serum levels and alcohol craving - an analysis using Lesch's typology. Neuropsychobiology 53 (2006) 133-136
15. Ishiguro H., Arinami T., Saito T., Akazawa S., Enomoto M., Mitushio H., et al. Association study between the -141C Ins/Del and TaqIA polymorphisms of the dopamine D2 receptor gene and alcoholism. Alcohol Clin Exp Res 22 (1998) 845-848
16. Jellinek E.M. The Disease Concept of Alcoholism. 1st ed. (1960), Hilhouse Press, New Brunswick, NJ
17. Johnson B.A. Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment. CNS Drugs 18 (2004) 1105-1118
18. Jonsson E., Cichon S., Gustavsson J., Grunhage F., Forslund K., Mattila-Evenden M., et al. Association between a promoter dopamine D2 receptor gene variant and the personality trait detachment. Biol Psychiatry 53 (2003) 577-584
19. Kiefer F., Helwig H., Tarnaske T., Otte C., Jahn H., and Wiedemann K. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome. Eur Addict Res 11 (2005) 83-91
20. Kohnke M., Wiatr G., Kolb W., Kohnke A., Schick S., Lutz U., et al. Plasma homovanillic acid: a significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase gene. Neuropsychopharmacology 28 (2003) 1004-1010
21. Lachman H., Papolos D., Saqito T., Yu Y., Szumlanski C., and Weinshilboum R. Human catechol-O-methyltranferase pharmacogenetics: description of functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
22. Lesch O.M., Dietzel M., Musalek M., Walter H., and Zeiler K. The course of alcoholism. Long-term prognosis in different types. Forensic Sci Int 36 (1988) 121-138
23. Lesch O.M., Kefer J., Lentner S., Mader R., Marx B., Musalek M., et al. Diagnosis of chronic alcoholism - classificatory problems. Psychopathology 23 (1990) 88-96
24. Lesch O., Riegler A., Gutierrez K., Hertling I., Ramskogler K., Semler B., et al. The European acamprosate trials: conclusions for research and therapy. J Biomed Sci 8 (2001) 89-95
25. Limosin F., Loze J., Boni C., Fedeli L., Hamon M., and Rouillon F. The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol dependent women. Neurosci Lett 362 (2004) 91-94
26. Melke J., Landen M., Baghei F., Rosmond R., Holm G., Bjorntorp P., et al. Serotonin transporter gene polymorphisms are associated with anxiety-related personality traits in women. Am J Med Genet 105 (2001) 458-463
27. Meyer-Lindenberg A., Kohn P., Kolachana B., Kippenhan S., McInerney-Leo A., and Nussbaum R. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci 8 (2005) 594-596
28. Miller S., Dykes D., and Plesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
29. Munafo M., Clark T., and Flint J. Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analysis. Mol Psychiatry 10 (2005) 415-419
30. Munafo M., Lingford-Hughes A., Johnstone E., and Walton R. Association between the serotonin transporter gene and alcohol consumption in social drinkers. Am J Med Genet 135 (2005) 10-14
31. Noble E.P. The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics 1 (2000) 309-333
32. Noble E.P. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet 116 (2003) 103-125
33. Nutt D. Alcohol and the brain. Pharmacological insights for psychiatrists. Br J Psychiatry 175 (1999) 114-119
34. Oroszi G., and Goldman D. Alcoholism: genes and mechanisms. Pharmacogenomics 5 (2004) 1037-1048
35. Parsian A., Cloninger C., and Zhang Z. Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism. Am J Med Genet 96 (2000) 407-411
36. Samochowiec J., Ladehoff M., Pelz J., Smolka M., Schmidt L., and Rommelspacher H. Predominant influence of the 3′-region of dopamine D2 receptor gene (DRD2) on the clinical phenotype in German alcoholics. Pharmacogenetics 10 (2000) 471-475
37. Samochowiec J., Kucharska-Mazur J., Grzywacz A., Jablonski M., Rommelspacher H., Samochowiec A., et al. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence. Neurosci Lett 410 (2006) 1-5
38. Sander T., Harms H., Podschus J., Finckh U., Nickel B., and Bander R. Dopamine D1-, D2-, and D3 receptor genes in alcohol dependence. Psychiatric Genet 5 (1995) 171-176
39. Sander T., Harms H., Podschus J., Finckh U., Nickel B., and Rolfs A. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 41 (1997) 299-304
40. SAS Institute: SAS/STST User's Guide (1988), Release 6.03 edition SAS Institute; Cary, NC.
41. Schmidt L., Harms H., Kuhn S., Rommelspacher H., and Sander T. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am J Psychiatry 155 (1998) 474-478
42. Schuckit M.A. The clinical implications of primary diagnostic groups among alcoholics. Arch Gen Psychiatry 42 (1985) 1043-1049
43. Spitzer R., Kroenke K., and Williams J. Validation and utility of a self-report version of PRIME-MD. the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 282 (1999) 1737-1744
44. Tiihonen J., Hallikainen T., Lachman H., Saito T., Volavka J., Kauhanen J., et al. Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry 4 (1999) 286-289
45. Vanderbergh D., Persico A., Hawkins A., Griffin C., Li X., and Jabs E. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14 (1992) 1104-1106
46. Walter H., Ramskogler K., Semler B., Lesch O.M., and Platz W. Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials. J Biomed Sci 8 (2001) 83-88
47. Wang T., Franke P., Neidt H., Cichon S., Knapp M., Lichtermann D., et al. Association study of the low-activity allele of catechol-O-methyltransferase and alcoholism using a family-based approach. Mol Psychiatry 6 (2001) 109-111
48. Wiesbeck G., Dursteler-MacFarland K., Wurst F., Walter M., Petitjean S., Muller S., et al. No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence. Addict Biol 11 (2006) 72-75
49. Windle M., and Scheit D. Alcoholic subtypes: are two sufficient?. Addiction 99 (2004) 1508-1519
50. Zucker R.A. The four alcoholisms: a developmental account of the etiologic process. Nebr Symp Motiv 34 (1987) 27-83 [1986]